The effect of oral magnesium citrate and magnesium oxide supplementation on hyperoxaluria and calcium oxalate supersaturation in kidney stone patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 99 人开始时间: 待定最近更新: 2019年12月17日

适应症

试验速览

暂无简介。

•Hyperoxaluria (24-hour urine oxalate over 40 and less than 80 mg)
•Patients with a history of kidney stone referred to kidney stone prevention clinic of Labbafinejad
•at least 20 days since the last treatment they have
•at least 3 months since following general dietary advice on recurrence prevention (drinking advice, high oxalate food restriction, animal protein restriction, fruit and vegetable intake encouragement, salt restriction and fat intake modification)
•willingness to cooperate in the study

•Primary or enteric hyperoxaluria (urine oxalate>80 mg/24h)
•Taking any drugs which affects calcium metabolism, including thiazides, potassium citrate, calcium supplement, magnesium supplement and Laxatives
•Taking any drugs which affects oxalate metabolism or calcium oxalate supersaturation, including vitamin B6
•History of diabetes mellitus, hepatic failure, thyroid or parathyroid diseases, chronic kiodney disease (CKD), Urinary tract infection (UTI), chronic diarrhea or immunologic diseases
•Pregnancy or lactation

发起方